Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Modified Research Career Development Award (K04)
Project #
5K04HL000953-04
Application #
3073592
Study Section
Metabolism Study Section (MET)
Project Start
1981-12-01
Project End
1986-11-30
Budget Start
1984-12-01
Budget End
1985-11-30
Support Year
4
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Oregon Health and Science University
Department
Type
Schools of Medicine
DUNS #
009584210
City
Portland
State
OR
Country
United States
Zip Code
97239
Leaf, D A; Connor, W E; Illingworth, D R et al. (1989) The hypolipidemic effects of gemfibrozil in type V hyperlipidemia. A double-blind, crossover study. JAMA 262:3154-60
Illingworth, D R; Connor, W E; Harris, W S (1988) Hypolipidemic effects of dietary omega-3 fatty acids in humans. Prog Clin Biol Res 255:243-53
Illingworth, D R (1987) Long term administration of lovastatin in the treatment of hypercholesterolaemia. Eur Heart J 8 Suppl E:103-11
Karanja, N; Morris, C D; Illingworth, D R et al. (1987) Plasma lipids and hypertension: response to calcium supplementation. Am J Clin Nutr 45:60-5
Illingworth, D R (1987) Lipid-lowering drugs. An overview of indications and optimum therapeutic use. Drugs 33:259-79
Wang, C S; Illingworth, D R (1987) Lipid composition and lipolytic activities in milk from a patient with homozygous familial hypobetalipoproteinemia. Am J Clin Nutr 45:730-6
Inkeles, S B; Connor, W E; Illingworth, D R (1986) Hepatic and dermatologic manifestations of chronic hypervitaminosis A in adults. Report of two cases. Am J Med 80:491-6
Illingworth, D R (1986) Comparative efficacy of once versus twice daily mevinolin in the therapy of familial hypercholesterolemia. Clin Pharmacol Ther 40:338-43
Illingworth, D R; Corbin, D (1985) The influence of mevinolin on the adrenal cortical response to corticotropin in heterozygous familial hypercholesterolemia. Proc Natl Acad Sci U S A 82:6291-4